Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission

Joan How, Kiran R. Vij, Maryam Ebadi, Todd E. DeFor, Rizwan Romee, Michelle M. Dolan, Celalettin Ustun, Daniel J. Weisdorf, Michael A. Linden, Armin Rashidi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)E381-E383
JournalAmerican Journal of Hematology
Issue number12
StatePublished - Dec 2018

Bibliographical note

Funding Information:
Research reported in this publication was supported by National Institutes of Health grant P30 CA77598 utilizing the Biostatistics and Bioin-formatics Core shared resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Cite this